QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines AYVAKIT® (avapritinib) in gastrointestinal stromal tumors tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Blueprint Medicines Co Expected to Post Q1 2024 Earnings of ($2 24) Per Share (NASDAQ:BPMC) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the second quarter ended.
Zai Lab (NASDAQ:ZLAB – Get Free Report) and Blueprint Medicines (NASDAQ:BPMC – Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability. Institutional and Insider Ownership 54.0% of Zai […]